Cases & Deals

Biolase Technology conducts inter partes reexamination of U.S. Patent No. 7,485,116

Clients Biolase Technology Inc.

Jones Day represents Biolase Technology Inc. in an inter partes reexamination of U.S. Patent No. 7,485,116.